Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How does the microbiome factor into neurodegenerative diseases?
Related Questions
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
What is the minimum level of cognitive symptoms that would prompt you to pursue biomarker testing required for anti-amyloid therapies for Alzheimer's?
How do you utilize FDG PET in the evaluation of dementias?
Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?
Do you use amyloid lowering therapy in patients on chronic anticoagulation?
How do you approach the medical evaluation of new onset psychosis in elderly patients?
What is your approach to patients who develop ARIA-E or ARIA-H during treatment with anti-amyloid therapies?
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
